menu
U.S. Sucralfate Industry Continues To Grow With Increasing Cases Of Duodenal And Gastric Ulcers In The U.S.
U.S. Sucralfate Industry Continues To Grow With Increasing Cases Of Duodenal And Gastric Ulcers In The U.S.
U.S. Sucralfate Market

Sucralfate is a cytoprotective agent that protects cells from damage caused by gastric acid, alcohol and acetylsalicylic acid. This medication comes in tablet and suspension forms. It was approved by the FDA in 1982. It is not considered to be safe for children. While its use is generally safe, children should not take it more often than prescribed. If the medication is prescribed for more than eight weeks, the patient should consult a doctor or pharmacist. The oral solution of sucralfate is a commonly prescribed medication for the treatment of intestine ulcers. It helps heal ulcers by forming a protective coating that prevents further injury and promotes healing. It is recommended to take the medication on an empty stomach at least 1 hour before a meal. The dosage of sucralfate is based on the medical condition of the patient. This medication is not suitable for use during pregnancy.

Read More:

https://medium.com/@dataguy.cmi/u-s-sucralfate-industry-continues-to-grow-with-increasing-cases-of-duodenal-and-gastric-ulcers-in-d11d65451fea

Click here for U.S. Sucralfate Market Report:

https://www.coherentmarketinsights.com/market-insight/us-sucralfate-market-2975

Click here for U.S. Sucralfate Market Press Release:

https://www.coherentmarketinsights.com/press-release/us-sucralfate-market-to-surpass-us-3882-million-by-2026-1825